Revolutionary Heart Disease Treatment Alert: Breakthrough Device Now Available Globally Through Exclusive Partnership with 3comma Medical

Pleasanton, California, September 11, 2024 - In a move that is set to revolutionize the treatment of heart diseases worldwide, FlowPhysix™ Inc, formerly known as Expanse ICE, has announced a strategic partnership with 3comma Medical / 3comma Medical GmbH to serve as the international commercial partner for the FLOWRUNNER™ Aspiration System.

This cutting-edge device has been making waves in the medical community, and its global availability is expected to have a significant impact on the treatment of cardiovascular diseases. The FLOWRUNNER™ Aspiration System is designed to provide a more effective and minimally invasive solution for removing blood clots and other obstructions from blood vessels, making it an attractive option for patients and healthcare professionals alike.

FlowPhysix™ Inc has been at the forefront of innovation in the medical device industry, and this partnership with 3comma Medical / 3comma Medical GmbH marks an important milestone in their mission to bring life-changing treatments to patients worldwide. 3comma Medical / 3comma Medical GmbH is a renowned medical device company with a strong track record of delivering innovative solutions to the global market.

"We are thrilled to partner with 3comma Medical / 3comma Medical GmbH to bring the FLOWRUNNER™ Aspiration System to patients around the world," said a spokesperson for FlowPhysix™ Inc. "This partnership marks a significant step forward in our mission to provide effective and minimally invasive solutions for the treatment of heart diseases, and we look forward to working together to make a meaningful difference in the lives of patients globally."

Heart disease is a leading cause of death worldwide, and the availability of effective treatment options is crucial in reducing mortality rates and improving patient outcomes. The FLOWRUNNER™ Aspiration System has the potential to revolutionize the treatment of heart diseases by providing a more effective and less invasive solution for removing blood clots and other obstructions from blood vessels.

With this partnership, FlowPhysix™ Inc and 3comma Medical / 3comma Medical GmbH are paving the way for a new era in the treatment of cardiovascular diseases. Patients and healthcare professionals around the world can expect to benefit from this innovative device, and the partnership is set to have a lasting impact on the global medical device industry.

For more information on FlowPhysix™ Inc and the FLOWRUNNER™ Aspiration System, please visit their website. To learn more about 3comma Medical / 3comma Medical GmbH, please visit their website.